Citigroup Inc Angiodynamics Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Angiodynamics Inc stock. As of the latest transaction made, Citigroup Inc holds 28,294 shares of ANGO stock, worth $193,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,294

Previous 9,073 211.85%

Holding current value

$193,248

Previous $54,000 307.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.51 - $7.84 $105,907 - $150,692	19,221 Added 211.85%	28,294 $220,000
Q2 2024 Aug 12, 2024	BUY	$5.65 - $7.03 $7,328 - $9,117	1,297 Added 16.68%	9,073 $54,000
Q1 2024 May 10, 2024	BUY	$5.27 - $8.03 $11,456 - $17,457	2,174 Added 38.81%	7,776 $45,000
Q4 2023 Feb 09, 2024	BUY	$6.17 - $8.04 $32,522 - $42,378	5,271 Added 1592.45%	5,602 $43,000
Q3 2023 Nov 09, 2023	SELL	$7.02 - $10.32 $226,387 - $332,809	-32,249 Reduced 98.98%	331 $2,000
Q2 2023 Aug 10, 2023	BUY	$8.29 - $11.16 $82,568 - $111,153	9,960 Added 44.03%	32,580 $339,000
Q1 2023 May 11, 2023	SELL	$9.1 - $15.48 $44,271 - $75,310	-4,865 Reduced 17.7%	22,620 $233,000
Q4 2022 Feb 09, 2023	BUY	$12.06 - $21.55 $60,131 - $107,448	4,986 Added 22.16%	27,485 $378,000
Q3 2022 Nov 10, 2022	BUY	$19.54 - $24.3 $26,418 - $32,853	1,352 Added 6.39%	22,499 $460,000
Q2 2022 Aug 10, 2022	SELL	$17.83 - $24.49 $291,021 - $399,725	-16,322 Reduced 43.56%	21,147 $409,000
Q1 2022 May 12, 2022	BUY	$20.46 - $29.16 $8,981 - $12,801	439 Added 1.19%	37,469 $807,000
Q4 2021 Feb 10, 2022	BUY	$24.35 - $30.97 $235,854 - $299,975	9,686 Added 35.42%	37,030 $1.02 Million
Q3 2021 Nov 10, 2021	BUY	$23.36 - $29.2 $638,755 - $798,444	27,344 New	27,344 $709,000

Others Institutions Holding ANGO

# of Institutions

141

Shares Held

32.8M

Call Options Held

8.9K

Put Options Held

View Full List

About ANGIODYNAMICS INC

Ticker ANGO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 39,107,800
Market Cap $267M
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...

More about ANGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account